Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Extension Study of ABP-19000 to Evaluate Safety and Efficacy of Repeat Treatments of ABP-450 in Cervical Dystonia

ClinicalTrials.gov ID: NCT04871451

Public ClinicalTrials.gov record NCT04871451. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 10:56 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-Label, Multicenter Study to Evaluate the Safety and Efficacy of Repeat Intramuscular ABP-450 (prabotulinumtoxinA) Injection for the Treatment of Cervical Dystonia

Study identification

NCT ID
NCT04871451
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
AEON Biopharma, Inc.
Industry
Enrollment
51 participants

Conditions and interventions

Interventions

  • ABP-450 Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 26, 2021
Primary completion
Jul 23, 2023
Completion
Jul 23, 2023
Last update posted
Aug 21, 2024

2021 – 2023

United States locations

U.S. sites
20
U.S. states
11
U.S. cities
19
Facility City State ZIP Site status
Arizona Neuroscience Research Phoenix Arizona 85032
Parkinson's and Movement Disorder Institute Fountain Valley California 92708
Neuro Pain Medical Center Fresno California 93710
Loma Linda University Loma Linda California 92354
New England Institute for Neurology and Headache Stamford Connecticut 06905
Infinity Clinical Research LLC Hollywood Florida 33024
Brainstorm Research Miami Florida 33176
University of South Florida Tampa Florida 33613
Neurology One Winter Park Florida 32792
Emory University Atlanta Georgia 30329
Rush University Medical Center Chicago Illinois 60612
Michigan State University East Lansing Michigan 48824
Quest Research Institute - Hunt - PPDS Farmington Hills Michigan 48334
University of New Mexico Albuquerque New Mexico 87106
The Cleveland Clinic Foundation Cleveland Ohio 44195
Cleveland Clinic Lou Ruvo Center for Brain Health Cleveland Ohio 89106
The Orthopedic Foundation New Albany Ohio 43054
Veracity Neuroscience LLC Memphis Tennessee 38157
Vanderbilt University Medical Center Nashville Tennessee 37232
Baylor College of Medicine Houston Texas 77030

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04871451, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 21, 2024 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04871451 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →